about
The full genome sequence of three strains of Jamestown Canyon virus and their pathogenesis in mice or monkeysGenome sequence analysis of La Crosse virus and in vitro and in vivo phenotypesLa Crosse virus infectivity, pathogenesis, and immunogenicity in mice and monkeysEvaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus.The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infectionHigh dose sertraline monotherapy fails to protect rhesus macaques from lethal challenge with Ebola virus Makona.A wild goose metapneumovirus containing a large attachment glycoprotein is avirulent but immunoprotective in domestic turkeysTahyna virus genetics, infectivity, and immunogenicity in mice and monkeys.A recombinant chimeric La Crosse virus expressing the surface glycoproteins of Jamestown Canyon virus is immunogenic and protective against challenge with either parental virus in mice or monkeys.Characterization of avian metapneumoviruses isolated in the USA.Interferon-β and Interferon-γ Are Weak Inhibitors of Ebola Virus in Cell-Based Assays.Evidence of avian pneumovirus spread beyond Minnesota among wild and domestic birds in central North America.Nonhuman Primate Models of Ebola Virus Disease.Lateral Flow Immunoassays for Ebola Virus Disease Detection in Liberia.Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names.Ebola Virus Neutralizing Antibodies Detectable in Survivors of theYambuku, Zaire Outbreak 40 Years after Infection.Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugs.Development of a novel real-time polymerase chain reaction assay for the quantitative detection of Nipah virus replicative viral RNA.Identification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell CulturesHeparan sulfate is an important mediator of Ebola virus infection in polarized epithelial cellsPan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection SurvivorsComparative Transcriptomics in Ebola Makona-Infected Ferrets, Nonhuman Primates, and HumansIn Vitro and In Vivo Activity of Amiodarone Against Ebola VirusFully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona IsolateEmergence of a Virulent Type C Avian Metapneumovirus in Turkeys in MinnesotaEbola Virus Isolation Using Huh-7 Cells has Methodological Advantages and Similar Sensitivity to Isolation Using Other Cell Types and Suckling BALB/c Laboratory MiceScalable, semi-automated fluorescence reduction neutralization assay for qualitative assessment of Ebola virus-neutralizing antibodies in human clinical samplesAcute transient tachypnea following gadoxetate administration in a rhesus macaque during contrast-enhanced magnetic resonance imaging
P50
Q21245105-4AA5482A-9B53-41A8-9308-BF349113BEDCQ27478428-872959B5-5AD0-43A9-9524-C655CE6B0FCBQ27485632-E6CCAD00-885D-49C7-8040-AF2BED264CDFQ28554599-F7C47A12-B1E7-4D27-81C2-4C69C8E2717AQ30252649-892BF9C8-C9BD-4275-AAB8-452F62D37799Q33919019-614BD6B0-4FFD-4083-B95A-13FCD37536E4Q34142727-19834B14-2504-49C4-B769-E01EE1EC71F4Q34173096-B3FA7CA8-4BE4-4305-9A34-353F17DF2409Q34225723-C6ECEDDA-1422-45CF-84D8-2EABF4A6FEF4Q35094547-F20AC24E-3A8A-415B-B1C1-5447C04DB462Q38709267-C1EA2A60-53BB-48DB-883C-EA6614AFF67DQ39129714-E112D5BC-F51C-431C-9B00-7A7593697D9EQ40051414-E6A319DC-7ED1-42B8-943A-07E44AFBEBB6Q40095646-F83A76D5-2F27-4CDD-B0E6-B4404BCB7A0DQ42934343-30A8FCA8-1897-415B-A637-D4ED8FEB6210Q46653237-CE158FA2-4F46-46BE-BBD4-6FB3FEC56376Q52724948-4B5E468F-A377-4325-A823-CC2B86DCC4AEQ55400316-CEF939D7-2440-4873-AB3E-5B78277074FBQ56355770-DF697223-B781-4597-BDA5-0FE25FE168FDQ57028947-28AC956C-9279-453B-A67D-40EB177A487BQ57092281-B4FBE86F-8F7C-4506-9B44-F8FD7A705F3DQ59350044-17850D72-8D9F-4FC2-B53B-08CFF98F9A10Q59356716-3DD25A66-4F14-4CA9-8F84-54DCA4A38B18Q59356876-8A0BBC57-22F9-4586-9F99-0E2CE5BE3FC2Q61910214-C0F48F85-0B43-43C8-8AA6-37B77FF0A351Q61910217-8ADFC0CC-CB72-4905-8FC5-97C1EB0E74A8Q92901041-3D9CDBC6-A101-44AE-9742-B851D3CD8EA2Q92967299-F083C779-63E8-4BB3-89E0-C72EC8E5590A
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Richard S Bennett
@ast
Richard S Bennett
@en
Richard S Bennett
@es
Richard S Bennett
@nl
ريتشارد إس بينيت
@ar
type
label
Richard S Bennett
@ast
Richard S Bennett
@en
Richard S Bennett
@es
Richard S Bennett
@nl
ريتشارد إس بينيت
@ar
prefLabel
Richard S Bennett
@ast
Richard S Bennett
@en
Richard S Bennett
@es
Richard S Bennett
@nl
ريتشارد إس بينيت
@ar
P106
P1153
55426171800
P21
P31
P496
0000-0002-7227-4831